Aia Group LTD Teva Pharmaceutical Industries LTD Transaction History

Aia Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$7.95 - $9.48 $35,655 - $42,517	-4,485 Reduced 33.11%	9,061 $82,000
Q3 2022 Nov 04, 2022	SELL	$6.86 - $11.95 $57,624 - $100,380	-8,400 Reduced 38.28%	13,546 $109,000
Q2 2022 Aug 11, 2022	BUY	$7.38 - $10.4 $34,870 - $49,140	4,725 Added 27.44%	21,946 $165,000
Q1 2022 May 06, 2022	BUY	$7.33 - $9.39 $34,905 - $44,715	4,762 Added 38.22%	17,221 $162,000
Q3 2021 Nov 05, 2021	BUY	$8.38 - $10.18 $104,406 - $126,832	12,459 New	12,459 $121,000

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.